Status:
COMPLETED
Comparison of CTrach, Intubating Laryngeal Mask Airway (ILMA) and I-gel for Tracheal Intubation
Lead Sponsor:
Northern Health and Social Care Trust
Conditions:
Intubation
Eligibility:
All Genders
18-89 years
Phase:
NA
Brief Summary
Various supraglottic airways may be used as a dedicated airway for insertion of intubating fibrescope and tracheal intubation in the patients with difficult to manage airways (Difficult Airway Society...
Detailed Description
Supraglottic airway devices such as I-LMa, Igel and LMA Ctrach are designed to create a "dedicated" airway which safely allows both spontaneous and controlled ventilation. The use of supraglottic airw...
Eligibility Criteria
Inclusion
- ASA I-III patients
- Age 18-89 years, males and females
- Elective surgical patients needing tracheal intubation
Exclusion
- ASA IV or V patients
- Emergency surgical procedures
- Patients at increased risk of aspiration
Key Trial Info
Start Date :
August 1 2009
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
September 1 2010
Estimated Enrollment :
120 Patients enrolled
Trial Details
Trial ID
NCT00983229
Start Date
August 1 2009
End Date
September 1 2010
Last Update
November 15 2010
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Antrim Area Hospital
Antrim, Antrim, United Kingdom, BT41 2RL